A new EU-funded Horizon 2020 project is set to help re-establish the Bogomoletz Institute of Physiology in the Ukrainian capital of Kyiv as an international centre of excellence in cellular and molecular neuroscience.
The project, named Neurotwin, which started in August this year, is worth nearly €780,000, with more than €380,000 going to the Bogomoletz Institute.
The money, taken from Horizon 2020’s widening pot, is intended to help the institute keep up with the latest developments in biology and build up new know-how and approaches to education.
The Bogomoletz institute used to be an important centre of expertise, hosting the world’s first intracellular perfusion in 1975. It is also responsible for breakthroughs in neuroreceptor research. After the collapse of the Soviet Union, the institute and the rest of Ukrainian science went through difficult times, with funding cuts and a brain drain of leading researchers.
Neurotwin will enable Ukrainian scientists to work with colleagues at the Technical University of Munich, University College London, Uppsala University, the Institute for Molecular and Cell Biology in Porto and Austria’s Centre for Social Innovation.
Horizon 2020 is the EU's biggest ever framework programme for financing and encouraging research and innovation projects, with a budget of €77 billion over seven years (2014–2020). The vast majority of this funding will be allocated on the basis of competitive calls that are open to applications from researchers, businesses and other interested organisations located in any of the EU Member States or countries associated to Horizon 2020, including the Eastern Neighbourhood countries Armenia, Georgia, the Republic of Moldova and Ukraine.
Find out more